Skip to main content
. 2016 May 3;3(1):e000093. doi: 10.1136/bmjgast-2016-000093

Table 2.

Summary of cost-effectiveness after 1 year of treatment

Treatment $ per MH achieved $ per 1 additional MH achieved
Infliximab 5 mg/kg every 8 weeks $99 171
Infliximab 10 mg/kg every 8 weeks $123 653 $1 243 310
Adalimumab 160/80/40 mg, 40 mg EOW $316 378 (Dominated)
Vedolizumab 300 mg every 8 weeks $301 969 (Dominated)

EOW, every other week; MH, mucosal healing.